Dataset Information


Future directions for serotonin and antidepressants.

ABSTRACT: Despite the widespread use of antidepressant medications that block serotonin (5-hydroxytryptamine; 5-HT) and/or norepinephrine (NE) transporters, such as SSRIs (selective serotonin reuptake inhibitors) or SNRIs (serotonin and norepinephrine reuptake inhibitors), the underlying neurobiological basis of action of these agents is poorly understood. Increases in serotonergic function are hypothesized to have beneficial effects on depressive symptoms. However, which of the 14 different neuronal receptors sensitive to 5-HT accounts for the therapeutic effects of SSRIs and SNRIs remains undetermined. The development of drugs that activate or block specific 5-HT receptors may help to circumvent the two main limitations of current antidepressants: low efficacy and delayed onset of therapeutic action. What follows is a short summary of the author's views on this matter.


PROVIDER: S-EPMC3547492 | BioStudies | 2013-01-01

SECONDARY ACCESSION(S): 10.1021/cn3001125

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3788746 | BioStudies
1000-01-01 | S-EPMC6132670 | BioStudies
1000-01-01 | S-EPMC4053958 | BioStudies
1000-01-01 | S-EPMC5459715 | BioStudies
2013-01-01 | S-EPMC3904662 | BioStudies
2015-01-01 | S-EPMC4685993 | BioStudies
1000-01-01 | S-EPMC3353132 | BioStudies
1000-01-01 | S-EPMC4772818 | BioStudies
2019-01-01 | S-EPMC6562183 | BioStudies
2015-01-01 | S-EPMC4270913 | BioStudies